Psyched Wellness Ltd. (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9) has announced that the company has inked a research contract with the National Research Council of Canada (NRC), an agency of the Government of Canada.
The NRC has been hired to provide their expertise in biomedical nanotechnology, but all the results of the research will belong to Psyched Wellness, and the NRC does not endorse the findings or itss products, the company said. The NRC specializes in providing vital scientific and technological services to the research and industrial communities of Canada.
Psyched Wellness said the contract will be divided into three objectives over a period of 2 years to further preliminary findings indicating anti-inflammatory and antioxidant properties in addition to the study of potential neuroprotective roles of the AME-1 extract.
READ: Psyched Wellness inks supply agreement for Amanita Muscaria dried mushroom caps
It noted that the study is the first successive one to further explore the neuroprotective, anti-inflammatory, and antioxidant nature of the AME-1 extract from the Amanita Muscaria mushroom concentrating on gut health and neuroprotection. Gut health can be impaired and lead to inflammation thus promoting a chronic condition of the gut lining and impairment of barrier function of the digestive tract.
The company said this is significant as gut health and immunity promotion is significant for the health and wellness of an individual. Neuroprotection is the preservation of neuronal structure or the rate of function. Preliminary evidence of a neuroprotective role of AME-1 would be a key initial step in the discovery of a new novel health and wellness property of the Amanita Muscaria mushroom.
"This investigative study will reveal key nutritional systematic and functional properties of the AME-1 extract. The Amanita Muscaria mushroom functional properties will be further investigated and identified in this scientific approach using modern scientific methods to help understand the functional neuroprotective and immune properties of AME-1," said Brian Tancowny, scientific advisor to Psyched.
Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The company's objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.
The company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.
Contact the author at jon.hopkins@proactiveinvestors.com